NCT02051335: Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults |
|
|
| Completed | 1 | 27 | Europe | Roflumilast, Daxas, Roflumilast placebo, Donepezil, Aricept, Donepezil placebo, Scopolamine, Hyoscine hydrobromide | AstraZeneca | Memory Impairment, Alzheimer's Disease | 05/14 | 05/14 | | |
NCT02079844: Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia |
|
|
| Completed | 1 | 20 | Europe | Roflumilast, DALIRESP®, DAXAS®, Placebo, Second generation antipsychotic | Takeda | Schizophrenia | 06/15 | 06/15 | | |
